Halofenate [halofenát]
topical
- Terms
-
MK-185
Persistent link
https://www.medvik.cz/link/D006218
Definition
An antihyperlipoproteinemic agent and uricosuric agent.
- DUI
- D006218 MeSH Browser
- CUI
- M0009769
- CAS
- Benzeneacetic acid, 4-chloro-alpha-(3-(trifluoromethyl)phenoxy)-, 2-(acetylamino)ethyl ester
- Previous indexing
- Glycolates (1966-1972); Antilipemic Agents (1966-1972); Anticholesteremic Agents (1966-1972)
- History note
- 91(73); was see under GLYCOLATES 1973-90
- Public note
- 91; was see under GLYCOLATES 1973-90
Allowable subheadings
- AD
- administration & dosage
- AE
- adverse effects
- AG
- agonists
- AA
- analogs & derivatives
- AN
- analysis
- AI
- antagonists & inhibitors
- BL
- blood
- CF
- cerebrospinal fluid
- CS
- chemical synthesis
- CH
- chemistry
- CL
- classification
- EC
- economics
- HI
- history
- IM
- immunology
- IP
- isolation & purification
- ME
- metabolism
- PK
- pharmacokinetics
- PD
- pharmacology
- PO
- poisoning
- RE
- radiation effects
- ST
- standards
- SD
- supply & distribution
- TU
- therapeutic use
- TO
- toxicity
- UR
- urine
...
Occurrences in Medvik records
D
Chemicals and Drugs
D02.241.081.018.386.682.850
Halofenate
D02.241.081.018.386.682.900
Ticrynafen
D02.241.223.601.375
Halofenate
D02.241.511.316.455
Halofenate